Related Experiment Video
Updated: Dec 1, 2025

13:35
Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
746
[Study on binding kinetics profiles of tea polyphenols-α-glucosidase interaction]
Pan Fu-Lu1, J I Yan-Hua1, Y U Guo-Hua2
1School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 102488, China.
Summary
Epigallocatechin gallate (ECG) and other tea polyphenols inhibit alpha-glucosidase. Mathematical models predict ECG
Area of Science:
- Biochemistry
- Pharmacology
- Enzyme Kinetics
Background:
- Tea polyphenols, including epigallocatechin gallate (ECG), epigallocatechin gallate (EGCG), and gallocatechin gallate (GCG), are known for their potential health benefits.
- Alpha-glucosidase is a key enzyme in carbohydrate digestion, and its inhibition is a target for managing conditions like type 2 diabetes.
- Understanding the synergistic effects and binding kinetics of these compounds is crucial for their therapeutic application.
Purpose of the Study:
- To evaluate the combination inhibition mechanism of ECG, EGCG, and GCG on alpha-glucosidase using the combination index (CI) method.
- To investigate the binding affinities and kinetic parameters of ECG, EGCG, and GCG with alpha-glucosidase using surface plasmon resonance (SPR).
- To establish and validate a predictive mathematical model for drug-alpha-glucosidase binding kinetics, considering different oral administration processes of ECG.
Main Methods:
- Combination Index (CI) method to assess synergistic inhibition.
- Surface Plasmon Resonance (SPR) analysis to determine binding affinities and kinetic parameters.
- Development and application of a mathematical model for drug-alpha-glucosidase interaction and concentration-time curves in the unstirred water layer.
- Validation of the predictive model using acarbose as a reference and comparison with clinical data.
Main Results:
- The study determined the binding affinities and kinetic parameters of ECG, EGCG, and GCG with alpha-glucosidase.
- A mathematical model was successfully developed to predict the dynamic process of drug-alpha-glucosidase binding kinetics.
- The model's predictions for ECG administration processes were validated against clinical performance, demonstrating its accuracy.
Conclusions:
- The findings provide insights into the synergistic inhibitory effects of tea polyphenols on alpha-glucosidase.
- The developed mathematical model accurately predicts drug-alpha-glucosidase binding kinetics, supporting the scientific rationale for multi-component traditional Chinese medicine combinations.
- The study validates the clinical characteristics of repeat administration for compounds like ECG, highlighting their therapeutic potential.
Keywords:
model of drug-α-glucosidase binding kineticsmolecular interactionsynergistic effectα-glucosidaseMore Related Videos
Related Concept Videos
Enzyme Inhibition
89.2K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
89.2K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
424
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
424

